Delivery Order SPE2DB20D3103-SPE2DB23FP1C0

Award Date 7/25/23
Potential Completion Date 7/26/23
Potential Value $1.8K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,541.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Omnipod Dash Pods (Gen 4) 5-packs, a medical device used in the management of diabetes. The contract is a delivery order placed under an existing Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running...
This federal contract award, valued at $3,723.99, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Omnipod Dash Pods (Gen 4) 5-packs, a medical device used in the management of diabetes. The award is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical. This IDC, valued at up to...
This federal contract award, valued at $3,137.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Omnipod Dash Pods (Gen 4) 5-packs, a medical device used in the management of diabetes. The contract is a firm fixed-price delivery order with a completion date of February 10, 2025. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp...
This federal contract award of $12,687.79 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Omnipod Dash Pods (Gen 4) 5-packs, which are medical devices used in the management of diabetes. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
This federal contract award, valued at $15,551.61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Omnipod Dash Pods (Gen 4) 5PK 5S, a medical device used in the management of diabetes. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $6,113.52, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Omnipod Dash Pods (Gen 4) 5-packs, a medical device used for diabetes management. This award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at up to $4,804.76, is for the delivery of Omnipod Dash Pods (Gen 4), a type of insulin pump, to the DLA. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to...
This federal contract award, valued at $6,869.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Omnipod Dash Pods (Gen 4) 5-packs, a medical device used for diabetes management. The contract is a delivery order, with a firm fixed price, and does not have a set-aside designation, indicating open competition. Amerisourcebergen, a major pharmaceutical distributor, has a significant Indefinite...
This is a $7,743.97 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Omnipod Dash Pods (Gen 4) 5-packs, which are medical devices used for the management of diabetes. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,280.38, is for the delivery of Omnipod Dash Pods (Gen 4) 5-packs to support federal healthcare programs. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 30, 2024. This award is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FP1C0
    Delivery Order

This federal contract award, valued at $1,827.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Omnipod Dash Pods (Gen 4) 5 packs, a medical device used for diabetes management.

The award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen, as a major pharmaceutical distributor, plays a critical role in supplying medical products to federal government agencies, including the Department of Defense and Department of Veterans Affairs healthcare systems.

Generated 2/27/25, 11:47 AM